CPSC Warns of SQM and Xinerter Bicycle Helmet Injury Risks

The manufacturers, based in China, are not recalling the bicycle helmets, nor providing consumers with any safety remedies or fixes, the CPSC warns.

Federal safety regulators are warning that certain bicycle helmets sold under the SQM and Xinerter brand names may pose a serious risk of injury or death for consumers, since they do not meet mandatory safety requirements. However, their Chinese manufacturers are refusing to issue a recall to remove the bicycle helmets from the market.

The Consumer Product Safety Commission (CPSC) issued two warning notices on July 20, impacting SQM bicycle helmets and Xinerter bicycle helmets, since they may fail to adequately protect users from head injuries during a crash or fall.

Consumers are being urged to immediately stop using both SQM and Xinerter bicycle helmets, which do not meet federal safety standards for bicycle helmets, because they do not comply with positional stability and certification requirements.

Manufacturers Refuse to Issue Bicycle Helmet Recalls

The helmets are sold by SQM and US-Xiner, both of whom are Chinese manufacturers. Both sellers have so far refused to recall the helmets and do not offer safety remedies or refunds to consumers, the CPSC warns.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

SQM bicycle helmets were sold in one size and are black with green accents, with a black and gray striped pattern, black and gray straps, and a red buckle. They have a label with “SQM2326, L(56-61 cm), ca. 225g, Made in China” located inside the helmet. They were sold online at amazon.com from March 2022 through January 2023 for between $17 and $26.

Xinerter bicycle helmets are teal with a white undershell, black straps, and a black buckle. “Xineter” is printed on the rear left and right side of the helmet. There is no label, model, or brand information inside the helmet. They were sold exclusively online at amazon.com from January 2020 through February 2021 for between $17 to $35.

The CPSC urges consumers to stop using the helmets, cut the straps, and dispose of the helmets immediately so no other person can mistakenly use the helmet.

Consumers should report any accidents or incidents involving product injuries or safety defects to CPSC at www.SaferProducts.gov.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria
Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria (Posted today)

Hundreds of currently pending Bard PowerPort lawsuits over infections, fractures and migration injuries were consolidated into a multidistrict litigation (MDL), but now even more claims present similar allegations that the implantable port catheter system has dangerous design defects that were not adequately disclosed by the manufacturer.

Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters
Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters (Posted today)

A recent report suggests that Johnson & Johnson is offering an additional $1.1 billion to settle talcum powder lawsuits, as part of a proposed $9 billion deal that would resolve all ovarian cancer claims as part of a third bankruptcy filing by the manufacturer.

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 3 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.